Biocept Banks $2.3M
Ryan McBride8/16/10
Biocept, a San Diego-based developer of cancer diagnostics, has raised $2.3 million of a planned $7.1 million round of equity financing, according to an SEC filing. Stephen Coutts, the company’s CEO, was not immediately available before business hours this morning to answer questions about the deal. The company, founded in 1997, brought in $3.6 million of a planned $4.1 million funding round in March.
